In vivo studies were also conducted in APPswe/PSEN1dE9 double transgenic mice (APP/PS1) and their wild‐type (WT) counterparts at early (6‐month‐old (mo) mice) and late (11 mo) AD stages. The gene discussed is APP; the disease is Alzheimer disease.